Physician profile
Andre Levesque
NPI 1467611566
$1,936.26
in general payments reported to CMS, 2019-2025
13 companies · $437 in 2025
The $437 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $97.51 · 2021: $309 · 2022: $248 · 2023: $318 · 2024: $359 · 2025: $437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,023 · Entertainment: $63.32 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,022.91 |
| Entertainment | $63.32 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $344.77 | 2024 | Ovitex 2s |
| Mentor Worldwide LLC | $309.19 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Abbvie INC. | $240.17 | 2023-2025 | |
| Integra Lifesciences Corporation | $234.79 | 2021-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Allergan, INC. | $211.40 | 2019-2023 | |
| Motiva USA, LLC | $196.20 | 2025 | |
| Galderma Laboratories, L.P. | $173.57 | 2021-2024 | Dysport |
| Argentum Medical | $63.32 | 2025 | |
| Apyx Medical Corporation | $62.08 | 2020 | |
| Merz North America, INC. | $29.41 | 2019 | |
| Davol INC. | $27.51 | 2022 | |
| Bard Peripheral Vascular, INC. | $21.95 | 2021 | |
| Polynovo North America LLC | $21.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Levesque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.